Skip to content

Comparing the Effectiveness of Two Ayurvedic Treatments for Benign Prostatic Hyperplasia (BPH) in Men: Sahacharadi Oil vs. Bala Oil Therapy.

Comparative evalutaion of Efficacy of Sahacharadi Tail Uttarbasti with Bala Tail Matarbasti in the Management of Vatashthila (Benign Prostatic Hyperplasia) - nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072783
Enrollment
40
Registered
2024-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Mahatma Gandhi Ayurveda College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing with Written informed Consent for will be taken. 2. Patient in the age group between 35-85years. 3. Patients with having mild to moderate BPH having Prostate size up to 50gm (Grade 3) will be included after screening. 4. Patients who are indicated for Matrabasti

Exclusion criteria

Exclusion criteria: 1.Patients of Grade 4 BPH i.e. above (50gm). 2.Patient suffering from Systemic disorders like uncontrolled Diabetes mellitus, Tuberculosis, Hypertension. 3.Urethral Stricture 4.Functional BOO (Bladder Outflow Obstruction) due to neurological conditions like CVA, Tabes Dorsalis, Parkinsonism, Disseminated Sclerosis, Loss of Neuro vesicle co-ordination, Syringomyelia, Alzheimers disease. 5.Carcinoma of Prostate 6.Diverticulum of the bladder 7.Trigone Hyperplasia 8.Disability due to old age and serious systemic illness 9.Acute and chronic Retention of urine

Design outcomes

Primary

MeasureTime frame
A decrease in International Prostate System (I-PSS) ScoreTimepoint: 1st follow up day 21 2nd follow up day 28 3rd follow up day 35

Secondary

MeasureTime frame
an increase in quality of lie due to urinary symptomsTimepoint: 1st follow up day 21 2nd follow up day 28 3rd follow up day 35

Countries

India

Contacts

Public ContactDr Sheetal Asutkar

Mahatma Gandhi Ayurveda College Hospital and Research Centre

sheetalasutkar16@gmail.com9766811974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026